Speaker illustration

Doctor Cinira Lefevre

Bristol-Myers Squibb, Rueil-Malmaison (France)

Which factors recorded during routine care predict treatment discontinuation of novel oral anticoagulants in patients with non-valvular atrial fibrillation?

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Atrial Fibrillation - Clinical and epidemiological aspects

Thumbnail

ESC 365 is supported by

logo Novo Nordisk